Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...

Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...

FEMSelect Launches Consumer Advocacy Campaign To Raise Awareness and Highlight Treatment Options for Pelvic Organ Prolapse NEWARK, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- FEMSelect Ltd., a women-led company developing groundbreaking solutions to advance women's health, today announced the launch of its Consumer Advocacy...